Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracordal trafermin (bFGF) for unilateral vocal fold paralysis
jRCTs031220681Active, not recruiting
- Start
- Jun 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of trafermin in Laryngeal Paralysis. Primary endpoint: Primary: VHI-10 improvement at day 180. Started Jun 2023; status: active, not recruiting.
02
Drugs
trafermin
03
Conditions
Laryngeal Paralysis
Beyond the preview
Go deeper on jRCTs031220681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220681.